{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:10:21Z","timestamp":1789042221597,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016545","name":"Roche Diagnostics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ajpc.2026.101643","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:44:29Z","timestamp":1776444269000},"page":"101643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatment"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2954-0695","authenticated-orcid":false,"given":"Gregory G.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Szarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa M.","family":"Cobbaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Renee","family":"Ruhaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schwertfeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera A.","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun G.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Stevanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagai","family":"Tavori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Reijnders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Romijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas J.M.","family":"van Neer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey D.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2026.101643_bib0001","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/jdi.14398","article-title":"Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes","volume":"16","author":"Hirano","year":"2025","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.ajpc.2026.101643_bib0002","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MOL.0000000000000824","article-title":"Small dense low-density lipoprotein particles: clinically relevant?","volume":"33","author":"Krauss","year":"2022","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ajpc.2026.101643_bib0003","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cca.2010.12.003","article-title":"Evaluation of a new homogenous method for detection of small dense LDL cholesterol: comparison with the LDL cholesterol profile obtained by density gradient ultracentrifugation","volume":"412","author":"Albers","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajpc.2026.101643_bib0004","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/j.jacc.2020.03.072","article-title":"Small dense low-density lipoprotein cholesterol predicts atherosclerotic cardiovascular disease in the copenhagen general population study","volume":"75","author":"Balling","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2026.101643_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241993","article-title":"Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: a systematic review and meta-analysis","volume":"15","author":"Liou","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpc.2026.101643_bib0006","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2023.01.015","article-title":"Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: the pooling project","volume":"367","author":"Schaefer","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2026.101643_bib0007","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/clinchem\/hvae061","article-title":"Impact of direct measurement of small dense low-density lipoprotein cholesterol for long-term secondary prevention in patients with stable coronary artery disease","volume":"70","author":"Koba","year":"2024","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajpc.2026.101643_bib0008","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.atherosclerosis.2016.06.019","article-title":"Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial","volume":"251","author":"Albers","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2026.101643_bib0009","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1515\/cclm-2019-1253","article-title":"Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM","volume":"58","author":"Langlois","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ajpc.2026.101643_bib0010","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.jacl.2023.10.009","article-title":"Effect of PCSK9 inhibition on plasma levels of small dense low density lipoprotein-cholesterol and 7-ketocholesterol","volume":"18","author":"Mahmood","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2026.101643_bib0011","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101643_bib0012","unstructured":"Roche Diagnostics, Small dense ldl seiken, Denka Co., Ltd, Niigata, Japan, V 1.0, https:\/\/elabdoc-prod.roche.com\/eLD\/api\/downloads\/cebb6101-18ff-ef11-2d91-005056a71a5d?countryIsoCode=XG (accessed 15 August 2025)."},{"key":"10.1016\/j.ajpc.2026.101643_bib0013","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/jalm\/jfae092","article-title":"Quality assurance for multiplex quantitative clinical chemistry proteomics in large clinical trials","volume":"9","author":"Reijnders","year":"2024","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.ajpc.2026.101643_bib0014","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajpc.2026.101643_bib0015","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.121.057807","article-title":"Apolipoprotein B, residual cardiovascular risk after acute coronary syndrome, and effects of alirocumab","volume":"146","author":"Hagstr\u00f6m","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101643_bib0016","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ajpc.2026.101643_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23282","article-title":"Precipitated sdLDL: an easy method to estimate LDL particle size","volume":"34","author":"Fernandez-Cidon","year":"2020","journal-title":"J Clin Lab Anal"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:23:29Z","timestamp":1789039409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726002187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":17,"alternative-id":["S2666667726002187"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101643","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101643"}}